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Pharyngeal dysphagia is a common, and
challenging complication that affects a
wide variety of oncology patients due to
surgical or radiation sequelae, tumor
burden, or other cancer treatments.
The modified barium swallow study
(MBS) is a dynamic x-ray study that is
commonly used in oncology (Fig. 1-2).
The MBS is widely accepted as a best
practice method to allow speechlanguage pathologists (SLP) to view the
patient's anatomy and physiology to
assess dysphagia.1,2
The DIGEST tool (Fig. 3) measures a
patient’s swallow function through safety
(how well food/liquid are kept out of the
lungs) and efficiency (how well
food/liquids are cleared out of the throat).
DIGEST fills a practice gap by providing
a summative, CTCAE aligned grade that
fits the needs of investigators and
clinicians.3
Feasibility of routine use of DIGEST in
the clinic needs to be examined further.

Figure 1. Lateral Scout View

The goal of this implementation
evaluation was to estimate the rate of
clinical reporting of DIGEST in MBS
studies as a marker of feasibility and to
describe the sources of missing DIGEST
grades.

MBS were conducted in diverse
cancer populations, in both outpatient
90%) and inpatient (10%)
setting. (Table 2)
Overall reporting rate of DIGEST was
93% in the 6-year period (Fig. 5) and
remained fairly steady year over
year.
The most common reason for
missing DIGEST in EHR record
was a history of total laryngectomy
(TL) (80%), followed by leak/fistula
resulting in an incomplete MBS study
(8%), and severe deviation from the
standard bolus protocol (5%) (Fig. 6).
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Methods
• This implementation evaluation followed
STARI framework. The retrospective data
review included consecutive MBS studies
conducted at a single comprehensive
cancer center over six years (2016-2021).
• DIGEST was the EBP tool.
• DIGEST reporting in the electronic health
record (EHR) was the implementation
outcome.
• 13,670 MBS records were identified with
flowsheet data (Fig. 4) exported from Epic
EHR, then chart abstracted to identify the
presence of DIGEST grade and sources
of missingness (Table 1).

Table. 2 Cohort characteristics/demographics (n=13,670 MBS)

Sex
Male
Female

Figure 3. DIGEST decision tree

Total Laryngectomy

Description

DIGEST
Completion Rate

10,005 (73%)
3,665 (27%)

9,278 (93%)
3,443 (94%)

1-56
57-64
65-71
72-96

1-56
57-64
65-71
72-96

Cancer Type
HNC
Thoracic
Neuro
Blood
Endocrine
Pediatric
Other solid tumors
No cancer history
Other

8,496 (62%)
487 (4%)
256 (2%)
466 (3%)
681 (5%)
74 (1%)
526 (4%)
21 (0.2%)
2663 (19%)

7,812 (92%)
469 (97%)
252 (98%)
453 (97%)
627 (92%)
68 (92%)
514 (97%)
17 (81%)
2490 (96%)

Status at MBS
Inpatient
Outpatient

1,322 (10%)
12,348 (90%)

1,208 (91%)
11,513 (93%)

1501 (11%)
2495 (18%)
2039 (15%)
36 (0.3%)
7071 (52%)
528 (4%)

1054 (70%)
2462 (99%)
2036 (99%)
0 (0%)
6694 (95%)
475 (90%)

Age
Q1 Range
Q2 Range
Q3 Range
Q4 Range

Figure 4. DIGEST grade reporting using flowsheets and note templates
in Epic Electronic Health Record

Reason

All MBS
n=13,670

Demographics

Figure 2. Silent Aspiration,
safety impaired

Table. 1 Thematic coding of reasons DIGEST grade could be
missing in EHR

Figure 6. Reasons for missing DIGEST scores in MBS notes from years
2016-2021 (n=949 MBS)

MBS Indication
Rule out leak
Swallow surveillance pathways
Baseline
Tracheoesophageal (TE) speech
Symptomatic
Other (no indication)

Other includes UADT obstructing FOV, degree of
oral dysphagia, and unknown.
1

Conclusions
•
•
•

•

Patient had a total laryngectomy.

Figure 5. DIGEST Reporting rate by year (2016-2021) after clinical
implementation of DIGEST (n=13,670 MBS encounters)

Bolus Protocol Deviation

Severe deviation from the standard
bolus protocol.

DIGEST Reporting by Year
4000

3500

Rule out leak/fistula

3% Other1

•

DIGEST proves to be feasible in the clinical
setting.
Further research is needed for standard
measures to evaluate dysphagia severity in
the TL population.
A deeper analysis of DIGEST
implementation should evaluate the
accuracy of clinical reporting as an
important component of fidelity of clinical
adoption.
Given feasibility of using DIGEST oncology
wide, beyond the HNC population in which
it was validated, argues for validation of the
tool in diverse cancer populations.
Educational opportunities are identified to
further facilitate dissemination and
implementation of DIGEST into clinical
practice.

MBS identified a leak or fistula.
3000
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Early MBS Termination

An MBS study was terminated
before a DIGEST grade could be
rendered.

93%

93%

94%
92%

95%

2000
92%
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Degree of Oral Dysphagia

UADT Obstructing FOV

Degree of oral phase dysphagia
precluded the SLP from deriving
DIGEST grade.

A medical device in the upper
aerodigestive tract is obstructing
the field of view.
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